Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 269 papers

Brexit from current guideline recommendations?

Angeli P, Piano S, Arroyo V; International Club of Ascites

Gut 2016, 65(11): 1919

DOI: http://dx.doi.org/10.1136/gutjnl-2016-312422

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

Ariza X, Graupera I, Coll M, Solà E, Barreto R, García E, Moreira R, Elia C, Morales-Ruiz M, Llopis M, Huelin P, Solé C, Fabrellas N, Weiss E, Nevens F, Gerbes A, Trebicka J, Saliba F, Fondevila C, Hernández-Gea V, Fernández J, Bernardi M, Arroyo V, Jiménez W, Deulofeu C, Pavesi M, Angeli P, Jalan R, Moreau R, Sancho-Bru P, Ginès P; CANONIC Investigators, EASL CLIF Consortium.

J Hepatol 2016, 65(1): 57–65

DOI: 10.1016/j.jhep.2016.03.002

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis

Solà E, Kerbert AJ, Verspaget HW, Moreira R, Pose E, Ruiz P, Cela R, Morales-Ruiz M, López E, Graupera I, Solé C, Huelin P, Navarro AA, Ariza X, Jalan R, Fabrellas N, Benten D, de Prada G, Durand F, Jimenez W, van der Reijden JJ, Fernandez J, van Hoek B, Coenraad MJ, Ginès P.

J Hepatol 2016, 65(5): 914–920

DOI: 10.1016/j.jhep.2016.07.003

Acute-on-chronic liver failure in cirrhosis

Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B.

Nat Rev Dis Primers 2016, 2: 16041

DOI: 10.1038/nrdp.2016.41

Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B

Li H, Chen LY, Zhang NN, Li ST, Zeng B, Pavesi M, Amorós À, Mookerjee RP, Xia Q, Xue F, Ma X, Hua J, Sheng L, Qiu DK, Xie Q, Foster GR, Dusheiko G, Moreau R, Gines P, Arroyo V, Jalan R.

Sci Rep 2016, 6: 25487

DOI: 10.1038/srep25487

Acute-on-chronic liver failure: A distinct clinical condition

Jalan R, Moreau R, Kamath PS, Arroyo V.

Semin Liver Dis 2016, 36(2): 107–108

DOI: 10.1055/s-0036-1583287

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)

Grønbæk H, Rødgaard-Hansen S, Aagaard NK, Arroyo V, Moestrup SK, Garcia E, Solà E, Domenicali M, Piano S, Vilstrup H, Møller HJ; CANONIC study investigators of the EASL-CLIF Consortium.

J Hepatol 2016, 64(4): 813–822

DOI: 10.1016/j.jhep.2015.11.021

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V.

J Hepatol 2015, 63(5): 1272–1284

DOI: 10.1016/j.jhep.2015.07.004

The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

Jalan R, Pavesi M, Saliba F, Amorós A, Fernandez J, Holland-Fischer P, Sawhney R, Mookerjee R, Caraceni P, Moreau R, Ginès P, Durand F, Angeli P, Alessandria C, Laleman W, Trebicka J, Samuel D, Zeuzem S, Gustot T, Gerbes AL, Wendon J, Bernardi M, Arroyo V; CANONIC Study Investigators; EASL-CLIF Consortium.

J Hepatol 2015, 62(4): 831–40

DOI: 10.1016/j.jhep.2014.11.012

Acute-on-chronic liver failure: Recent concepts

Moreau R, Jalan R, Arroyo V.

J Clin Exp Hepatol 2015, 5(1): 81–85

DOI: 10.1016/j.jceh.2014.09.003

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024